Bioasis Technologies (CN: BTI)

Last close As at 27/03/2024

0.26

−0.04 (−13.33%)

Market capitalisation

19m

Edison Investment Research is terminating coverage on Bioasis Technologies. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Bioasis Technologies — Shifting gears to R&D

Healthcare | Update

Bioasis Technologies — Platform licensed to Chiesi

Healthcare | Initiation

Bioasis Technologies — Bringing brain drugs into the 21st century

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Bioasis Technologies. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free